PDF herunterladen
Synlett 2010(1): 101-106  
DOI: 10.1055/s-0029-1218530
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Efficient Copper-Catalyzed Synthesis of 4-Aminoquinazoline and 2,4-Diaminoquinazoline Derivatives

Xiaobo Yanga,b, Hongxia Liuc, Hua Fu*a, Renzhong Qiao*b, Yuyang Jiangc, Yufen Zhaoa
a Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing 100084, P. R. of China
Fax: +86(10)62781695; e-Mail: fuhua@mail.tsinghua.edu.cn;
b State Key Laboratory of Chemical Resource Engineering, Department of Pharmaceutical Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, P. R. of China
e-Mail: qiaorz@mail.buct.edu.cn;
c Key Laboratory of Chemical Biology, Guangdong Province, College of Shenzhen, Tsinghua University, Shenzhen 518057, P. R. of China
Weitere Informationen

Publikationsverlauf

Received 21 September 2009
Publikationsdatum:
01. Dezember 2009 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

We have developed an efficient copper-catalyzed method for the synthesis of 4-aminoquinazoline and 2,4-diaminoquinazoline derivatives via reactions of substituted 2-bromo-benzonitriles with amidines or guanidine, and the method is of economical and practical advantage.

Key words

copper - Ullmann-type reaction - cross-coupling - quinazoline - synthetic method

    References and Notes

  • 1 Ple PA. Green TP. Hennequin LF. Curwen J. Fennell M. Allen J. Lambertvan der Brempt C. Costello G. J. Med. Chem.  2004,  47:  871 
    CrossrefPubMedGoogle Scholar
  • 2a Colotta V. Catarzi D. Varano F. Lenzi O. Filacchioni G. Costagli C. Galli A. Ghelardini C. Galeotti N. Gratteri P. Sgrignani J. Deflorian F. Moro S. J. Med. Chem.  2006,  49:  6015 
    Google Scholar
  • 2b Lewerenz A. Hentschel S. Vissiennon Z. Michael S. Nieber K. Drug Dev. Res.  2003,  58:  420 
    Google Scholar
  • 3 Malecki N. Carato P. Rigo G. Goossens JF. Houssin R. Bailly C. Henichart JP. Bioorg. Med. Chem.  2004,  12:  641 
    CrossrefPubMedGoogle Scholar
  • 4a Doyle LA. Ross DD. Oncogene  2003,  22:  7340 
    Google Scholar
  • 4b Henderson EA. Bavetsias V. Theti DS. Wilson SC. Clauss R. Jackman AL. Bioorg. Med. Chem.  2006,  14:  5020 
    Google Scholar
  • 5a Chien T.-C. Chen C.-S. Yu F.-H. Chern J.-W. Chem. Pharm. Bull.  2004,  52:  1422 
    Google Scholar
  • 5b Herget T. Freitag M. Morbitzer M. Kupfer R. Stamminger T. Marschall M. Antimicrob. Agents Chemother.  2004,  48:  4154 
    Google Scholar
  • 6a Waisser K. Gregor J. Dostal H. Kunes J. Kubicova L. Klimesova V. Kaustova J. Farmaco  2001,  56:  803 
    Google Scholar
  • 6b Kunes J. Bazant J. Pour M. Waisser K. Slosarek M. Janota J. Farmaco  2000,  55:  725 
    Google Scholar
  • 7a Nakagami K, Yokoi S, Nishimura K, Nagai S, Honda T, Oda K, Fujii K, Kobayashi R, and Kojima M. inventors; US  4323680. 
  • 7b Haley GJ. inventors; US  5373011. 
  • 8a Palanki MSS, and Suto MJ. inventors; US  5939421. 
  • 8b Myers MR, Spada AP, Maguire MP, Persons PE, Zilberstein A, Hsu C.-Y.-J, and Johnson SE. inventors; US  5714493. 
  • 9a Barker AJ. inventors; US  5942514. 
  • 9b Barker AJ. inventors; US  5932574. 
  • 10a Nauta WT. inventors; US  3980650. 
  • 10b Mizogami S, Hiranuma H, Sekiya T, and Hanazuka M. inventors; US  4607034. 
  • 11a Elslager EF. Davoll J. In Lectures in Heterocyclic Chemistry 2   Castle RN. Townsend LB. Hetero Corp.; Orem Utah (USA): 1974. 
    Google Scholar
  • 11b Elslager EF. Johnson JL. Werbel LM. J. Med. Chem.  1983,  26:  1753 
    Google Scholar
  • 12 Grivsky EM. Lee S. Sigel CW. Duch DS. Nichol CA. J. Med. Chem.  1980,  23:  327 
    CrossrefPubMedGoogle Scholar
  • 13a Bertino JR. Sawacki WL. Moroson BA. Cashmore AR. Elslager EF. Biochem. Pharmacol.  1979,  28:  1983 
    Google Scholar
  • 13b Weir EC. Cashmore AR. Dreyer RN. Graham ML. Hsiao N. Moroson BA. Sawacki WL. Bertino JR. Cancer Res.  1982,  42:  1696 
    Google Scholar
  • 13c Duch DS. Edelstein MP. Bowers SW. Nichol CA. Cancer Res.  1982,  42:  3987 
    Google Scholar
  • 13d Lin JT. Cashmore AR. Baker M. Dreyer RN. Ernstoff M. Marsh JC. Bertino JR. Whitfield LR. Delap R. Grillo-Lopez A. Cancer Res.  1987,  47:  609 
    Google Scholar
  • 13e Kovacs JA. Allegra CA. Swan JC. Drake JC. Parillo JE. Chabner BA. Masur H. Antimicrob. Agents Chemother.  1988,  32:  430 
    Google Scholar
  • 14 Am. J. Hosp. Pharm.  1994,  51:  591 
    PubMedGoogle Scholar
  • 15a Graffner-Nordberg M. Fyfe M. Brattsand R. Mellgård B. Hallberg A. J. Med. Chem.  2003,  46:  3455 
    Google Scholar
  • 15b Graffner-Nordberg M. Marelius J. Ohlsson S. Persson A. Swedberg G. Andersson P. Andersson SE. Åqvist J. Hallberg A. J. Med. Chem.  2000,  43:  3852 
    Google Scholar
  • 15c Graffner-Nordberg M. Kolmodin K. Åqvist J. Queener SF. Hallberg A. J. Med. Chem.  2001,  44:  2391 
    Google Scholar
  • 16 Thurmond J. Butchbach MER. Palomo M. Pease B. Rao M. Bedell L. Keyvan M. Pai G. Mishra R. Haraldsson M. Andresson T. Bragason G. Thosteinsdottir M. Bjornsson JM. Coovert DD. Burghes AHM. Gurney ME. Singh J. J. Med. Chem.  2008,  51:  449 
    CrossrefPubMedGoogle Scholar
  • 17a Chowdhury SF. Villamor VB. Guerrero RH. Leal I. Brun R. Croft SL. Goodman JM. Maes L. Ruiz-Pérez LM. Pacanowska DG. Gilbert IH. J. Med. Chem.  1999,  42:  4300 
    Google Scholar
  • 17b Chowdhury SF. Guerrero RH. Brun R. Ruiz-Pérez LM. Pacanowska DG. Gilbert IH. J. Enzym. Inhib. Med. Chem.  2002,  17:  293 
    Google Scholar
  • 17c Pez D. Leal I. Zuccotto F. Boussard C. Brun R. Croft SL. Yardley V. Ruiz-Pérez LM. Gonzalez-Pacanowska D. Gilbert IH. Bioorg. Med. Chem.  2003,  11:  4693 
    Google Scholar
  • 18 Vaidya CM. Wright JE. Rosowsky A. J. Med. Chem.  2002,  45:  1690 
    CrossrefPubMedGoogle Scholar
  • 19 Stevens MFG. J. Chem. Soc. C  1967,  1096 
    CrossrefGoogle Scholar
  • 20 Sutherland DR. Tennant G. J. Chem. Soc., Perkin Trans. 1  1974,  534 
    CrossrefGoogle Scholar
  • 21 Seijas JA. Vázquez-Tato MP. Martínez MM. Tetrahedron Lett.  2000,  41:  2215 
    CrossrefGoogle Scholar
  • 22 Rad-Moghadam K. Samavi L. J. Heterocycl. Chem.  2006,  43:  913 
    CrossrefGoogle Scholar
  • 23 Rosowsky A. Chen H. J. Org. Chem.  2001,  66:  7522 
    CrossrefPubMedGoogle Scholar
  • For recent reviews on copper-catalyzed N-arylation, see:
  • 24a Kunz K. Scholz U. Ganzer D. Synlett  2003,  2428 
    Google Scholar
  • 24b Ley SV. Thomas AW. Angew. Chem. Int. Ed.  2003,  42:  5400 
    Google Scholar
  • 24c Beletskaya IP. Cheprakov AV. Coord. Chem. Rev.  2004,  248:  2337 
    Google Scholar
  • 24d Evano G. Blanchard N. Toumi M. Chem. Rev.  2008,  108:  3054 ; and references cited therein
    Google Scholar
  • For recent studies on the synthesis of N-heterocycles through Ullmann-type couplings, see:
  • 25a Martin R. Rodríguez R. Buchwald SL. Angew. Chem. Int. Ed.  2006,  45:  7079 
    Google Scholar
  • 25b Evindar G. Batey RA. J. Org. Chem.  2006,  71:  1802 
    Google Scholar
  • 25c Bonnaterre F. Bois-Choussy M. Zhu J. Org. Lett.  2006,  8:  4351 
    Google Scholar
  • 25d Zou B. Yuan Q. Ma D. Angew. Chem. Int. Ed.  2007,  46:  2598 
    Google Scholar
  • 25e Yuan X. Xu X. Zhou X. Yuan J. Mai L. Li Y. J. Org. Chem.  2007,  72:  1510 
    Google Scholar
  • 26a Liu X. Fu H. Jiang Y. Zhao Y. Angew. Chem. Int. Ed.  2009,  48:  348 
    Google Scholar
  • 26b Huang C. Fu Y. Fu H. Jiang Y. Zhao Y. Chem. Commun.  2008,  6333 
    Google Scholar
  • 26c Yang D. Fu H. Hu L. Jiang Y. Zhao Y. J. Org. Chem.  2008,  73:  7841 
    Google Scholar
27

General Procedure for the Synthesis of Compounds 3a-m A 25 mL round-bottom flask was charged with a magnetic stirrer and DMF (3 mL), substituted 2-bromobenzonitrile (1, 1 mmol), amidine hydrochloride (2, 1.2 mmol), DMEDA (0.2 mmol, 18 mg), and K2CO3 (2 mmol, 138 mg) [2 mmol (656 mg) of Cs2CO3 were used for acetamidine hydro-chloride] after stirring of the mixture for 15 min under nitrogen atmosphere, and CuI (0.1 mmol, 19 mg) was added to the flask. The mixture was stirred at 80 ˚C for the time indicated in Table  [²] . The resulting mixture was cooled to r.t. and filtered. The solid was washed with DMF (2 × 3 mL), and the combined filtrate was concentrated by the rotary evaporator, and the residue was purified by column chromatography on silica gel using CHCl3-MeOH (40:1 to 5:1) as eluent to give the desired product.
Cyclopropyl-4-aminoquinazoline (3c)
Eluent CHCl3-MeOH (40:1). Yield 134 mg (72%). White solid; mp 198-200 ˚C. ¹H NMR (300 MHz, DMSO-d 6): δ = 8.12 (d, 1 H, J = 7.9 Hz), 7.58 (m, 4 H), 7.34 (t, 1 H, J = 7.4 Hz), 1.99 (m, 1 H, J = 7.5 Hz), 1.05-0.87 (m, 4 H). ¹³C NMR (75 MHz, DMSO-d 6): δ = 167.6, 162.3, 150.5, 133.2, 126.9, 124.5, 124.0, 113.4, 18.4, 9.4. HRMS: m/z calcd for C11H11N3 [M + H]+: 186.1031; found: 186.1037.